JP2023518980A5 - - Google Patents

Info

Publication number
JP2023518980A5
JP2023518980A5 JP2022558098A JP2022558098A JP2023518980A5 JP 2023518980 A5 JP2023518980 A5 JP 2023518980A5 JP 2022558098 A JP2022558098 A JP 2022558098A JP 2022558098 A JP2022558098 A JP 2022558098A JP 2023518980 A5 JP2023518980 A5 JP 2023518980A5
Authority
JP
Japan
Prior art keywords
seq
sequence number
sequence
expression construct
artificial expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022558098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518980A (ja
JP7749577B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/024525 external-priority patent/WO2021195591A2/en
Publication of JP2023518980A publication Critical patent/JP2023518980A/ja
Publication of JP2023518980A5 publication Critical patent/JP2023518980A5/ja
Priority to JP2025157795A priority Critical patent/JP2026001073A/ja
Application granted granted Critical
Publication of JP7749577B2 publication Critical patent/JP7749577B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022558098A 2020-03-27 2021-03-26 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物 Active JP7749577B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025157795A JP2026001073A (ja) 2020-03-27 2025-09-24 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063001159P 2020-03-27 2020-03-27
US63/001,159 2020-03-27
PCT/US2021/024525 WO2021195591A2 (en) 2020-03-27 2021-03-26 Artificial expression constructs for selectively modulating gene expression in non-neuronal brain cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025157795A Division JP2026001073A (ja) 2020-03-27 2025-09-24 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物

Publications (3)

Publication Number Publication Date
JP2023518980A JP2023518980A (ja) 2023-05-09
JP2023518980A5 true JP2023518980A5 (enExample) 2024-02-27
JP7749577B2 JP7749577B2 (ja) 2025-10-06

Family

ID=77890746

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022558098A Active JP7749577B2 (ja) 2020-03-27 2021-03-26 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物
JP2025157795A Pending JP2026001073A (ja) 2020-03-27 2025-09-24 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025157795A Pending JP2026001073A (ja) 2020-03-27 2025-09-24 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物

Country Status (6)

Country Link
US (1) US12655444B2 (enExample)
EP (1) EP4127182A4 (enExample)
JP (2) JP7749577B2 (enExample)
AU (1) AU2021242353A1 (enExample)
CA (1) CA3173609A1 (enExample)
WO (1) WO2021195591A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022169884A2 (en) * 2021-02-02 2022-08-11 Allen Institute Artificial expression constructs for modulating gene expression in gabaergic neurons and astrocytes
CA3233342A1 (en) * 2021-10-05 2023-04-13 Tanya DAIGLE Artificial expression constructs for modulating gene expression in the cerebellum and a secondary cell type
EP4536835A2 (en) * 2022-06-13 2025-04-16 Allen Institute Artificial expression constructs for modulating gene expression in non-neuronal central nervous system cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602680B2 (en) 2000-07-14 2003-08-05 The Regents Of The University Of California Production of gabaergic cells
WO2003093479A1 (en) 2002-05-01 2003-11-13 University Of Florida Research Foundation, Inc. Improved raav expression systems and methods for enhancing transduction of mammalian neural cells
US20080039413A1 (en) 2003-10-21 2008-02-14 Morris David W Novel compositions and methods in cancer
US9617548B2 (en) 2008-04-22 2017-04-11 Vib Vzw Liver-specific nucleic acid regulatory elements and methods and use thereof
WO2013155222A2 (en) * 2012-04-10 2013-10-17 The Regents Of The University Of California Brain-specific enhancers for cell-based therapy
KR102616820B1 (ko) 2017-03-17 2023-12-21 애드베룸 바이오테크놀로지스, 인코포레이티드 향상된 유전자 발현을 위한 조성물 및 방법
WO2019068854A1 (en) * 2017-10-06 2019-04-11 Ospedale San Raffaele S.R.L. GENE THERAPY OF NEURODEGENERATIVE DISEASES USING VAA VECTORS
US11364309B2 (en) * 2017-11-10 2022-06-21 Norwegian University Of Science And Technology (Ntnu) Neuronal enhancers
EP3781174A4 (en) * 2018-04-09 2022-01-26 Allen Institute RESCUE OF VOLTAGE CONTROLLED SODIUM CHANNEL FUNCTION IN INHIBITORY NEURONS

Similar Documents

Publication Publication Date Title
US20230295659A1 (en) TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs)
JP2023123765A (ja) 中枢神経系を標的化したａａｖベクター
KR102649543B1 (ko) 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도
KR102167668B1 (ko) 고 형질도입 효율 raav 벡터, 조성물 및 사용 방법
CN109844124A (zh) 年龄相关疾病和病症的基因治疗方法
CN112040988A (zh) 修饰的aav衣壳多肽用于治疗肌肉疾病
WO2016122791A1 (en) Spinal subpial gene delivery system
JP2017513861A (ja) 末梢性ニューロパチー及び運動ニューロン疾患の治療方法
JP2018506530A5 (enExample)
JP2022513339A5 (enExample)
US20250032550A1 (en) A novel way for brain-specific delivery of molecules for the treatment of brain diseases
AU2020367437B2 (en) Gene therapy for Alzheimer's disease
KR20240110849A (ko) Aadc/gdnf 폴리뉴클레오티드 및 이의 파킨슨병 치료에 있어서의 용도
KR102616559B1 (ko) N-아세틸갈락토사민 결합 폴리펩티드에 기초한 mRNA 표적 분자 및 이의 제조 방법
WO2004035779A1 (ja) ウイルスエンベロープを用いた生体分子の導入方法ならびにそのための組成物およびシステム
CN121794391A (zh) 用于治疗帕金森病的基因治疗载体及其用途
JP2022058346A (ja) グルコーストランスポーター１発現用アデノ随伴ウイルスベクター
JP2023529833A5 (enExample)
JP2024505027A5 (enExample)
JP2025184867A (ja) 出血性脳卒中の治療のための機能的ニューロンの再生
JP2024519955A5 (enExample)
JP2024537165A5 (enExample)
CA3225312A1 (en) Composition and method for treating hemophilia b
KR102828335B1 (ko) Gne 근육병 치료용 aav 기반의 유전자 치료제
CN121344099A (zh) 一种小鼠心肌纤维化病理模型诱导剂